Peter Wersäll

5.4k citations

68 papers · 3.7k indexed · 1 hit paper · h-index 25

Impact in

Radiation top 2%
- Advanced Radiotherapy Techniques
Oncology top 2%
- Cancer Immunotherapy and Biomarkers

Papers in

Radiation 16
- Advanced Radiotherapy Techniques 16
Pulmonary and Respiratory Medicine 33
- Renal cell carcinoma treatment 13
- Lung Cancer Diagnosis and Treatment 10

Co-authors: Hans von der Maase Peter Albers Pedro Sánchez‐Rovira T. Oliver Malcolm J. Moore Christian Lippert Steen Werner Hansen J.T. Roberts
Journals: Acta Oncologica (12 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)Radiotherapy and Oncology (5 papers)Cancer Immunology Immunotherapy (5 papers)Physica Medica (2 papers)
Partner nations: Sweden Denmark Netherlands

In The Last Decade

Peter Wersäll

67 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study 2000 · 1.7k citations

Peers

Countries citing papers authored by Peter Wersäll

Since Specialization

Citations

This map shows the geographic impact of Peter Wersäll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wersäll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wersäll more than expected).

Fields of papers citing papers by Peter Wersäll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Wersäll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wersäll. The network helps show where Peter Wersäll may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Wersäll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Wersäll Line = papers co-authored together Peter Wersäll links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study Journal of Clinical Oncology ·Hans von der Maase, Steen Werner Hansen, J.T. Roberts, Luigi Dogliotti, T. Oliver, Malcolm J. Moore, I. Bodrogi, Peter Albers, Alexander Knuth, Christian Lippert, Pierre Kerbrat, Pedro Sánchez‐Rovira, Peter Wersäll, Simon Cleall, D. Roychowdhury, 刘增光, Carla Visseren‐Grul, Pierfranco Conté	2023	19
2	Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases Clinical and Translational Radiation Oncology ·姚石, María Laura Andrés, Peter Wersäll, Zhiqing Xiao, Rolf Lewensohn, Giuseppe Masucci, Karin Lindberg	2022	1
3	Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy Physica Medica ·Kristin Karlsson, Ingmar Lax, 阿部絵美, Vitali Grozman, Karin Lindberg, Peter Wersäll, Gavin Poludniowski	2021	7
4	Evaluation of third treatment week as temporal window for assessing responsiveness on repeated FDG-PET-CT scans in Non-Small Cell Lung Cancer patients Physica Medica ·Woo-Gun Jeong, P O F E S S O R '- rrex, Sara Carvalho, Wouter van Elmpt, Philippe Lambin, Alexandru Daşu, Peter Wersäll, Iuliana Toma-Daşu	2018	8
5	Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005–2014 Radiotherapy and Oncology ·Mathias Stenman, Edward A. Riegelmann, Paulina Paavola, Peter Wersäll, Ulrika Harmenberg, Maria Lindskog	2018	54
6	Non-linear conversion of HX4 uptake for automatic segmentation of hypoxic volumes and dose prescription Acta Oncologica ·张杭华, Charles E. Bryant, Alexandru Daşu, P O F E S S O R '- rrex, Aniek J.G. Even, Wouter van Elmpt, Philippe Lambin, Peter Wersäll, Iuliana Toma-Daşu	2017	8
7	OA24.05 The Nordic HILUS-Trial - First Report of a Phase II Trial of SBRT of Centrally Located Lung Tumors Journal of Thoracic Oncology ·Karin Lindberg, Per Bergström, Odd Terje Brustugun, Silke Engelholm, Vitali Grozman, Morten Høyer, Kristin Karlsson, Azza A. Khalil, Charlotte Kristiansen, Ingmar Lax, Britta Lödén, Jan Nyman, Gitte Fredberg Persson, Zhigguo Huo, Peter Wersäll, Rolf Lewensohn	2017	38
8	Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer Biology of Blood and Marrow Transplantation ·Brigitta Omazic, Mats Remberger, Lisbeth Barkholt, S. Choudhury, 曾凡富, Peter Wersäll, Bo‐Göran Ericzon, Jonas Mattsson, Olle Ringdén	2015	8
9	Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT – the Nordic experience Acta Oncologica ·Karin Lindberg, Jan Nyman, Kirby B., Morten Høyer, 清一小笠原, Ingmar Lax, Peter Wersäll, Kristin Karlsson, Signe Friesland, Rolf Lewensohn	2015	60
10	Radiation-induced Changes in Levels of Selected Proteins in Peripheral Blood Serum of Breast Cancer Patients as a Potential Triage Biodosimeter for Large-scale Radiological Emergencies Health Physics ·Marta Deperas-Kamińska, Arcadio Briseño, Michał Marczyk, Joanna Polańska, Peter Wersäll, Elisabet Lidbrink, Elizabeth A. Ainsbury, Katherine L. W. Burns, Marc Benderitter, Siamak Haghdoost, Andrzej Wójcik	2014	10
11	Radiation-induced stress response in peripheral blood of breast cancer patients differs between patients with severe acute skin reactions and patients with no side effects to radiotherapy Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Helge Gerndt, Ingemar Näslund, 児玉華子, Aleksandra Kantypowicz, Peter Wersäll, Elisabet Lidbrink, Mats Harms‐Ringdahl, Andrzej Wójcik, Siamak Haghdoost	2013	22
12	Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney Acta Oncologica ·Christer Svedman, Kristin Karlsson, R.M. Brooke, Per Sandström, Henric Blomgren, Ingmar Lax, Peter Wersäll	2008	68
13	A Systematic Overview of Radiation Therapy Effects in Skeletal Metastases Acta Oncologica ·Sture Falkmer, Johannes Järhult, Peter Wersäll, Eva Cavallin‐Ståhl	2003	118
14	Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study Journal of Clinical Oncology ·Hans von der Maase, Steen Werner Hansen, J.T. Roberts, Luigi Dogliotti, T. Oliver, Malcolm J. Moore, I. Bodrogi, Peter Albers, Alexander Knuth, Christian Lippert, Pierre Kerbrat, Pedro Sánchez‐Rovira, Peter Wersäll, Simon Cleall, D. Roychowdhury, 刘增光, Carla Visseren‐Grul, Pierfranco Conté Hit paper breakdown →	2000	1678
15	Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma Cancer Immunology Immunotherapy ·Kolluru Kusuma Harnath Sai, Peter Ragnhammar, Jan Fagerberg, Jan‐Erik Frödin, Juan Antonio imp. Tarazona, AGNES MUENI MUTINDA, Maria Liljefors, Bo Nilsson, J. Shetye, Peter Wersäll, Håkan Mellstedt	1999	16
16	Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma Cancer Immunology Immunotherapy ·Peter Wersäll, Mr. Sandeep Kumar, Peter Biberfeld, V. Peter Collins, Ph. DEPONGE, S. Larsson, Håkan Mellstedt, J. Boëthius	1997	61
17	Induction of a T- and B-cell response against a unique amino acid sequence of the mouse IgG2A hinge region in a MAb-treated patient International Journal of Cancer ·Peter Wersäll, Jan Fagerberg, Ji-Young Chyung, Ulla Rudén, J. Boëthius, Hákan Mellstedt	1997	1
18	Diverse effect of cytokine treatment of tumor cells on specific versus non-specific cytotoxicity Medical Oncology and Tumor Pharmacotherapy ·Hirofumi Naganuma, Eva Halapi, Giuseppe Masucci, Mona Hansson, Peter Wersäll, Christina Hising, Venkateswaran Subramanian, Håkan Mellstedt, Rolf Kiessling	1992	2
19	Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity Cancer Immunology Immunotherapy ·Peter Wersäll, Giuseppe Masucci, Håkan Mellstedt	1991	10
20	Lymphokine Activated Killer (LAK) Cells in Antibody Dependent Cellular Cytotoxicity (ADCC) Using MAb 17-1A: A Combination of Potential Usefulness in Tumor Therapy Hybridoma ·Giuseppe Masucci, Peter Wersäll, Lívia Versiani Duarte PINTO, P.H.J. Kelly, Hans Wigzell, Håkan Mellstedt	1989	16

About Peter Wersäll

Peter Wersäll is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Genetics and Transplantation, having authored 68 papers that have together received 3.7k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (16 papers), Renal cell carcinoma treatment (13 papers), Immunotherapy and Immune Responses (10 papers), Lung Cancer Diagnosis and Treatment (10 papers), Immune Cell Function and Interaction (9 papers), Medical Imaging Techniques and Applications (7 papers), T-cell and B-cell Immunology (7 papers) and Glioma Diagnosis and Treatment (6 papers). The work is most often cited by research in Radiation (428 citations), Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.4k citations), Surgery (1.8k citations) and Urology (219 citations). Peter Wersäll has collaborated with scholars based in Sweden, Denmark and Netherlands. Frequent co-authors include Hans von der Maase, Peter Albers, Pedro Sánchez‐Rovira, T. Oliver, Malcolm J. Moore, Christian Lippert, Steen Werner Hansen, J.T. Roberts, Simon Cleall and Pierfranco Conté. Their work appears in journals such as Acta Oncologica, International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology, Cancer Immunology Immunotherapy and Physica Medica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact